SNCA and Parkinson disease: We aimed to investigate whether α-synuclein-related serum EV miRNAs (miR-7, miR-153, miR-214, miR-155, miR-21, and miR-200a) are associated with symptom severity, cognitive impairment, and quality of life in PD patients.